Click on image to view larger version.

Figure 6 Influence of naloxone treatment on the plasma levels of cholesterol (A) , triglycerides (B) , low-density lipoprotein (LDL) (C) , and high-density lipoprotein (HDL) (D) . Apolipoprotein-E–deficient mice received an IP injection of 10 mg/kg/day (n = 8), 20 mg/kg/day (n = 7), or 25 mg/kg/day (n = 5) naloxone, or phosphate-buffered saline (n = 8) for 10 weeks. The results are expressed as mean values ± SD.